N/A
Completed N=256
Fostering MAT Use in Justice Populations
Opioid Use Disorder · Recidivism
Source: ClinicalTrials.gov NCT04363320 ↗
Enrolled (actual)
256
Serious AEs
0.0%
Results posted
May 2025
Primary outcomePrimary: Mean Number of New Eligible Justice Involved Persons Initiated With MOUD Per Month: Intervention Phase — 20.36; 0.55; 4.47; 2.03 New Justice Involved Persons per month — p=0.002
Summary
The grant will test two timely and successful evidence-based implementation practices, NIATx Coaching and ECHO, with jail/community-based healthcare providers to increase medication assisted treatment (MAT) use with justice populations.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Mean Number of New Eligible Justice Involved Persons Initiated With MOUD Per Month: Intervention Phase |
20.36; 0.55; 4.47; 2.03; 21.79; 3.00 | 0.002 sig |
| PRIMARY Mean Number of New Eligible Justice Involved Persons Initiated With MOUD Per Month: Sustainability Phase |
28.29; 0.01; 4.67; 2.41; 30.37; 3.3 | 0.485 |
| PRIMARY Mean Total Number of Eligible Justice Involved Persons on MOUD Per Month: Intervention Phase |
98.73; 0.08; 56.58; 0.94; 104.07; 117.62 | 0.00002 sig |
| PRIMARY Mean Total Number of Eligible Justice Involved Persons on MOUD Per Month: Sustainability Phase |
110.19; 0.01; 77.22; 1.96; 127.32; 154.78 | 0.045 sig |
| PRIMARY Change in Number of Prescribers Using MOUD |
— | — |
| SECONDARY MOUD Sustainability Measured Using the Program Sustainability Assessment Tool |
44.79487; 43.75385; 43.16667; 43.96226; 50.71429; 50.78571 | — |
Eligibility Criteria
Site Inclusion Criteria:
- Have an interest in embedding or increasing the use of MOUD within their site.
- Have the funds to pay for medications for the duration of the study (24 months); whether it be from grants, insurance or private pay.
- Sites agree to implement or continue to use at least one medication, although they will be encouraged to offer more than one medication.
- Have leadership support at all levels.
- Agree to provide data described in the MOU or Information Sheet.
Exclusion Criteria
- N/A
Data sourced from ClinicalTrials.gov (NCT04363320). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.